More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$55.41B
EPS
1.29
P/E ratio
22.5
Price to sales
4.49
Dividend yield
4.301%
Beta
0.761427
Previous close
$31.46
Today's open
$31
Day's range
$30.26 - $31.01
52 week range
$27.57 - $56.33
CEO
Erik Engstrom
Employees
34580
Headquarters
London,
Exchange
New York Stock Exchange
Shares outstanding
1.82B
Issue type
American Depository Receipt
Industrials
Corporate Services
LexisNexis Risk Solutions Named a Leader in IDC MarketScape: U.S. Provider Data Management for Payers 2025-2026 Vendor Assessment
The IDC MarketScape recognizes the company's strengths in data volume, quality, completeness, coverage and compliance with directory mandates ATLANTA, Feb. 24, 2026 /PRNewswire/ -- LexisNexis® Risk Solutions has once again been named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025-2026 Vendor Assessmenti. The IDC MarketScape study utilizes quantitative and qualitative research to assess the capabilities and business strategies of many of the most prominent provider data management (PDM) vendors for the payer enterprise.
PRNewsWire • 14 hours ago

RELX: An Undervalued Stock With Consistent Growth And Recurring Revenue
Founded in 1993, but with roots dating back to the late 1800s, RELX is now a $56 billion (by market cap) data and analytics giant that employs more than 35,000 people. RELX has now increased its dividend for 15 consecutive years. Its 10-year dividend growth rate is 7.7%. RELX has a good financial position. The long-term debt/equity ratio is 1.5, while the interest coverage ratio is nearly 10.
Seeking Alpha • Feb 23, 2026

LexisNexis Risk Solutions Launches AI-Powered Identity Management Platform for Healthcare
Industry-leading identity verification, resolution and enrichment solutions combine with leading AI authentication capabilities to secure, unify and enrich patient identities across the care journey ATLANTA, Feb. 19, 2026 /PRNewswire/ -- LexisNexis® Risk Solutions today announced the launch of an identity management platform with industry leading identity verification, resolution and enrichment solutions that enable healthcare organizations to manage patient and member identities across the entire healthcare journey. Configured specifically for healthcare use cases, the platform enables organizations to confidently verify identities, resolve duplicate records and continuously enhance profiles with social and behavioral insights from beyond their organization.
PRNewsWire • Feb 19, 2026

UK's RELX plans pay boost for CEO Engstrom, Sky News reports
British information group RELX is preparing to grant its top boss, Erik Engstrom, a substantial pay rise, bringing it closer to its FTSE-100 peers like AstraZeneca , Rolls-Royce and Shell , Sky News reported on Wednesday, citing sources.
Reuters • Feb 18, 2026

U.S. Auto Insurance Policy Shopping and New Business Growth Continue to Break Records in Q4 with "Hot" Readings on the LexisNexis® U.S. Insurance Demand Meter
ATLANTA, Feb. 18, 2026 /PRNewswire/ -- Shopping for U.S. auto insurance remained in high gear through the fourth quarter of 2025, according to the latest U.S. Insurance Demand Meter from LexisNexis® Risk Solutions. The quarterly year-over-year shopping growth registered "Hot", rising to 6.9% on the Demand Meter, while new policy growth also clenched a "Hot" reading, increasing to 7.1%.
PRNewsWire • Feb 18, 2026

Impax International Sustainable Economy Fund Q4 2025 Contributors And Detractors
Impax International Sustainable Economy Fund portfolio marginally underperformed MSCI EAFE benchmark, driven primarily by stock-specific effects and style tilts. AstraZeneca's stock has an attractive Sustainability Lens profile with opportunities in Health Care Access & Innovation and Wellbeing. RELX's stock has a high Corporate Resilience score due primarily to environmental and social risk management practices.
Seeking Alpha • Feb 18, 2026

RELX: Brokers back the investment story despite AI fears, targets cut on de-rating
RELX PLC (LSE:REL) shares rose 6% after it remained a 'buy' at both Deutsche Bank and UBS following full-year 2025 results, although both banks reduced their price targets to reflect sector de-rating and higher discount rates. Deutsche cut its price target to 3,050p from 3,700p, while UBS moved to 3,600p from 4,570p.
Proactive Investors • Feb 13, 2026

Relx should deal with the ‘Claude Crash' by buying back shares – and then buy more | nils pratley
The firm remains confident even as the market flips from seeing it as an AI winner to fearing its profit market will implode
The Guardian • Feb 12, 2026

RELX rebounds as results and £2.25bn buyback take edge off AI fears
RELX PLC shares rose 3.6% to 2,085p on Thursday after full-year results met expectations and management unveiled a larger than forecast £2.25 billion share buyback. The stock remains more than 33% lower than a month ago and down over 40% in six months, hit by wider concerns that advances in artificial intelligence could disrupt parts of its data and publishing operations.
Proactive Investors • Feb 12, 2026

RELX PLC (RELX) Q4 2025 Earnings Call Transcript
RELX PLC (RELX) Q4 2025 Earnings Call Transcript
Seeking Alpha • Feb 12, 2026

¹ Disclosures

Open an M1 investment account to buy and sell RELX PLC PLC American Depositary Shares (Each representing One) commission-free¹. Build wealth for the long term using automated trading and transfers.